For instance, ibrutinib, an irreversible molecular inhibitor of Bruton's tyrosine kinase (BTK), was shown to reverse T cell suppression mediated by murine MDSC in a neuroblastoma mouse model [193]. Here, BTK is linked to neuroblastoma.